Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial | BMJ Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Neurology

Protocol

Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial

Online download statistics by month:

Online download statistics by month: March 2022 to September 2023

	Abstract	Full	Pdf
Mar 2022	1044	1034	182
Apr 2022	152	156	61
May 2022	129	125	72
Jun 2022	109	114	38
Jul 2022	129	130	21
Aug 2022	75	70	26
Sep 2022	75	69	33
Oct 2022	41	46	40
Nov 2022	64	61	21
Dec 2022	37	35	10
Jan 2023	70	68	45
Feb 2023	62	62	29
Mar 2023	73	66	22
Apr 2023	68	49	18
May 2023	49	42	32
Jun 2023	73	64	17
Jul 2023	31	29	12
Aug 2023	45	40	19
Sep 2023	33	31	11
Total	2359	2291	709